The article discusses about the heparin prophylaxis for venous thromboembolism (VTE). The study found that deep vein thrombosis (DVT) in medical patients cannot to prevented and also found there is no benefit for heparin prophylaxis. The counselling given to the medical patients are highlighted....
BACKGROUND: Inflammatory bowel disease (IBD) and colorectal surgery are risk factors for deep venous thrombosis (DVT). The aim of this prospective study was to evaluate the effectiveness of standardized prophylactic low molecular weight heparin (LMWH) therapy in patients who underwent surgery for ulce...
Heparin prophylaxis has no benefit in medical patients for venous thromboembolism (VTE) is misconceived.1 It is not true that most cases of deep vein thrombosis (DVT) in medical patients can be prevented. ... hwadmin - BMJ 被引量: 0发表: 2012年 More data on heparin prophylaxis for nonsurg...
VTE Prophylaxis GuidelinesInternational Medical Prevention Registry on Venous Thromboembolism (IMPROVE)Padua Risk Assessment ScoreBackground: Venous thromboembolism (VTE) is a common complication seen during or after hospitalization that manifests as deep venous thrombosis (DVT) and/or pulmonary embolism (PE...
PCV18: COST EFFECTIVENESS OF ENOXAPARIN VS. UNFRACTIONATED HEPARIN FOR THE PROPHYLAXIS OF DVT AND SUBSEQUENT LONG-TERM COMPLICATIONS IN TOTAL HIP REPLACEMENT SURGERY IN THE UNITED KINGDOMPCV18: COST EFFECTIVENESS OF ENOXAPARIN VS. UNFRACTIONATED HEPARIN FOR THE PROPHYLAXIS OF DVT AND SUBSEQUENT LONG-TE...
In a randomized prospective trial, the efficacy of low molecular weight heparin (LMWH) (Fragmin®) and dextran 70 (Macrodex®) in preventing deep vein thrombosis (DVT) in the legs was evaluated in 98 consecutive patients undergoing elective total hip replacement. The patients were randomly all...
Standard unfractionated heparin (UFH) has been in clinical use for over 50 years. The commercial use of low molecular weight heparins (LMWHs) began in the mid 1980s for hemodialysis and the prophylaxis of deep vein thrombosis (DVT). Initially, the clinical development of LMWHs was concentrated...
LMWH has a greater bioavailability and appears to be as effective as unfractionated heparin for both treatment and prophylaxis of DVT; this is especially so in the outpatient setting. LMWH has resulted in shorter hospitalizations and reduced incidence of major bleeding complications. ...
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against...Compares preoperative and postoperative results of the use of low-molecular-weight heparin (LMWH) prophylaxis for deep vein thrombosis (DVT) in patients undergoing elective hip replacement. Method of data ...
Low molecular weight heparins (LMWHs) are now universally accepted as drugs of choice for post-surgical prophylaxis of deep vein thrombosis (DVT). Currently these agents are also being developed for the treatment of thrombosis and various cardiovascular indications. Due to manufacturing differences, ...